Validation of an Instrument to Measure Quality of Life in British Children With Inflammatory Bowel Disease
Authors:
- 1 September 2011
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 53 (3) , 280-286
Abstract
Objective: To validate IMPACT‐III (UK), a health‐related quality of life (HRQoL) instrument, in British children with inflammatory bowel disease (IBD).Patients and Methods: One hundred six children and parents were invited to participate. IMPACT‐III (UK) was validated by inspection by health professionals and children to assess face and content validity, factor analysis to determine optimum domain structure, use of Cronbach alpha coefficients to test internal reliability, ANOVA to assess discriminant validity, correlation with the Child Health Questionnaire to assess concurrent validity, and use of intraclass correlation coefficients to assess test‐retest reliability. The independent samples t test was used to measure differences between sexes and age groups, and between paper and computerised versions of IMPACT‐III (UK).Results: IMPACT‐III (UK) had good face and content validity. The most robust factor solution was a 5‐domain structure: body image, embarrassment, energy, IBD symptoms, and worries/concerns about IBD, all of which demonstrated good internal reliability (α = 0.74–0.88). Discriminant validity was demonstrated by significant (*P < 0.05, **P < 0.01) differences in HRQoL scores between the severe, moderate, and inactive/mild symptom severity groups for the embarrassment scale (63.7* vs 81.0 vs 81.2), IBD symptom scale (45.0** vs 64.2* vs 80.6), and the energy scale (46.4* vs 62.1* vs 77.7). Concurrent validity of IMPACT‐III (UK) with comparable domains of the Child Health Questionnaire was confirmed. Test‐retest reliability was confirmed with good intraclass correlation coefficients of 0.66 to 0.84. Paper and computer versions of IMPACT‐III (UK) collected comparable scores, and there were no differences between the sexes and age groups.Conclusions: IMPACT‐III (UK) appears to be a useful tool to measure HRQoL in British children with IBD.Keywords
This publication has 23 references indexed in Scilit:
- Measuring Quality of Life in Pediatric Patients With Inflammatory Bowel Disease: Psychometric and Clinical CharacteristicsJournal of Pediatric Gastroenterology and Nutrition, 2008
- Pilot Evaluation of an Instrument to Measure Quality of Life in British Children With Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2008
- Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel diseaseInflammatory Bowel Diseases, 2006
- Health-related Quality of Life Improves in Children and Adolescents with Inflammatory Bowel Disease After Attending a Camp Sponsored by the Crohnʼs and Colitis Foundation of AmericaInflammatory Bowel Diseases, 2005
- A comparison of Likert scale and visual analogue scales as response options in children's questionnairesActa Paediatrica, 2004
- Quality of Life in Children and Adolescents with Cystic FibrosisPediatric Drugs, 2003
- The IMPACT Questionnaire: A Valid Measure of Health-Related Quality of Life in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2002
- Quality of Life in Children with Crohn's DiseaseJournal of Pediatric Gastroenterology and Nutrition, 1996
- Mental Health and Psychological Functioning in Children and Adolescents with Inflammatory Bowel Disease: a Comparison with Children having Other Chronic Illnesses and with Healthy ChildrenJournal of Child Psychology and Psychiatry, 1992
- The rating form of IBD patient concerns: a new measure of health status.Psychosomatic Medicine, 1991